Investigative Urology - Results from #6720

A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer - Abstract August 30, 2011

Inactivation of the von Hippel-Lindau tumour suppressor gene induces Neuromedin U expression in renal cancer cells - Abstract August 30, 2011

The impact of hypertriglyceridemia on prostate cancer development in patients aged ≥60 years - Abstract August 29, 2011

Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA - Abstract August 29, 2011

Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancer - Abstract August 29, 2011

Resistance to CYP17A1 inhibition with abiraterone in castration resistant prostate cancer: Induction of steroidogenesis and androgen receptor splice variants - Abstract August 26, 2011

Castration resistant prostate cancer is associated with increased blood vessel stabilization and elevated levels of VEGF and Ang-2 - Abstract August 26, 2011

Baculoviruses as gene therapy vectors for human prostate cancer - Abstract August 26, 2011

Association of PITX2 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis - Abstract August 25, 2011

Manserin as a novel histochemical neuroendocrine marker in prostate cancer - Abstract August 25, 2011

Anti-proliferative and pro-apoptotic activities of hydroxytyrosol on different tumour cells: The role of extracellular production of hydrogen peroxide - Abstract August 25, 2011

TMPRSS2-ERG status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate - Abstract August 24, 2011

The dietary isoflavone biochanin-A sensitizes prostate cancer cells to TRAIL-induced apoptosis - Abstract August 24, 2011

Comprehensive genome methylation analysis in bladder cancer;identification and validation of novel methylated genes and application of these as urinary tumor markers - Abstract August 24, 2011

Prostate cancer stem cells: Are they androgen-responsive? - Abstract August 23, 2011

FDA grants fast track designation to Bayer’s investigational compound Alpharadin™ for the treatment of castration resistant prostate cancer in patients with bone metastases August 23, 2011

Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer - Abstract August 22, 2011

Genetic variation in myeloperoxidase modifies the association of serum γ-tocopherol with aggressive prostate cancer among current smokers - Abstract August 19, 2011

Do molecular biomarkers have prognostic value in primary T1G3 bladder cancer treated with bacillus Calmette-Guerin intravesical therapy? - Abstract August 19, 2011

Interactions between genetic variants and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium - Abstract August 18, 2011

Page 337 of 346